Comparative effectiveness of rasburicase versus allopurinol for cancer patients with renal dysfunction and hyperuricemia-Reference-Cited by-同舟云学术

Comparative effectiveness of rasburicase versus allopurinol for cancer patients with renal dysfunction and hyperuricemia

Published:2020-02 Issue: Volume:89 Page:106298
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Martens Kylee L.^ORCID,Khalighi Parisa R.,Li Shan,White Andrew A.,Silgard Emily,Frieze Deborah,Estey Eli,Garcia David A.,Hingorani Sangeeta,Li Ang^ORCID

Funder

National Hemophilia Foundation

Shire

Conquer Cancer Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference20 articles.

1. Current concepts: the tumor lysis syndrome;Howard;N. Engl. J. Med.,2011

2. In-hospital outcomes of tumor lysis syndrome: a population-based study using the national inpatient sample;Durani;Oncologist,2017

3. Prognostic significance of acute renal injury in acute tumor lysis syndrome;Darmon;Leuk. Lymph.,2010

4. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus;Cairo;Br. J. Haematol.,2010

5. A clinical and economic comparison of rasburicase and allopurinol in the treatment of patients with clinical or laboratory tumor lysis syndrome;Cairo;Clin. Lymphoma Myeloma Leuk.,2017

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumour lysis syndrome;Nature Reviews Disease Primers;2024-08-22

2. Tumor Lysis Syndrome;JAP Academy Journal;2023-10-12

3. Use of rasburicase to improve kidney function in children with hyperuricemia and acute kidney injury;Clinical and Experimental Nephrology;2023-09-26

4. Rasburicase in treating tumor lysis syndrome: An umbrella review;Cancer Pathogenesis and Therapy;2023-07

5. Daily serum phosphate increase as early and reliable indicator of kidney injury in children with leukemia and lymphoma developing tumor lysis syndrome;Pediatric Nephrology;2023-03-21